Current Investigations

Securities Fraud

Filing Deadline: December 2, 2025
Filing Deadline: October 10, 2025
Filing Deadline: October 13, 2025
Filing Deadline: October 13, 2025
Filing Deadline: October 20, 2025
Filing Deadline: October 21, 2025
Filing Deadline: October 28, 2025
Filing Deadline: November 12, 2025
Filing Deadline: November 14, 2025
Filing Deadline: November 17, 2025
Filing Deadline: November 18, 2025
Filing Deadline: November 21, 2025

Governance & Derivative

Mergers & Acquisitions

KSF Attorney Reflects on Navigating Law with a Disability

James Fetter, an associate at KSF who is blind, participated in a panel discussion hosted by the ABA Commission on Disability Rights about navigating the legal profession with a disability.

Read More »

Final Approval of $27.5 Million Settlement Granted in Aimmune Merger Litigation

After more than four years of litigation, the Hon. Maxine Chesney entered a Final Judgment approving a $27.5 million settlement for the Class in a Class action against Aimmune Therapeutics.

Read More »

KSF Wins Class Certification in Credit Suisse Securities Litigation

On July 7, 2025, the court certified a class of shareholders and noteholders in In re: Credit Suisse Securities Fraud Class Actions (Diabat), No. 1:23-cv-05874-CM (S.D.N.Y.), a securities fraud class action pending in the United States District Court for the Southern District of New York.

Read More »

Final Approval of $13 Million Settlement Granted in CarLotz Securities Litigation

On July 7, 2025, a Final Judgment of $13 million settlement of the Class’s claims in Hogan v. Pilgrim’s Pride Corporation et al., was approved.

Read More »

Final Approval of $41.5 Million Settlement Granted in Pilgrim’s Pride Securities Litigation

On June 17, 2025, a Final Judgment of $41.5 million settlement of the Class’s claims in Hogan v. Pilgrim’s Pride Corporation et al., was approved.

Read More »